Zydus receives final approval from the USFDA for Febuxostat Tablets
Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Subscribe To Our Newsletter & Stay Updated